J B Chemicals and Pharmaceuticals Ltd

JBCHEPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹12,292 cr, stock is ranked 288
Low RiskStock is 1.94x as volatile as Nifty
1,590.5516.40 (+1.04%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹12,292 cr, stock is ranked 288
Low RiskStock is 1.94x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
27.44
PB RatioPB Ratio
6.78
Dividend YieldDiv. Yield
1.04%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

88%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).

Investor PresentationView older 

Feb 14, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020211.451.681.832.150.140.190.270.45
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.91%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 20, 2022

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investors/Analysts Meet with management | Download

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about Investors/Analysts Meet with management | Download

Intimation of Board Meeting 
Announced OnMay 11, 2022

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2022, inter alia, to consider and approve {i) audited financial statements/annual financial results for the financial year ended on March 31, 2022; and {ii) recommendation of final dividend, if any, for financial year 2021-22. | Download

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2022, inter alia, to consider and approve {i) audited financial statements/annual financial results for the financial year ended on March 31, 2022; and {ii) recommendation of final dividend, if any, for financial year 2021-22. | Download

Cash Dividend 
Ex. DateFeb 23, 2022

Interim • Div/Share: ₹ 8.5

See all events